Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine/human) RANKL - Kostenuik, P J; Nguyen, H Q; McCabe, J; Warmington, K S; Kurahara, C; Sun, N; Chen, C; Li, L; Cattley, R C; Van, G; Scully, S; Elliott, R; Grisanti, M; Morony, S; Tan, H L; Asuncion, F; Li, X; Ominsky, M S; Stolina, M; Dwyer, D; Dougall, W C; Hawkins, N; Boyle, W J; Simonet, W S; Sullivan, J K (J Bone Miner Res, 2009)